A Pilot Exercise Study for PTSD in Women Veterans
Study Details
Study Description
Brief Summary
The overall aim of this pilot feasibility study is to determine if 12-week moderate intensity exercise can safely alleviate posttraumatic symptoms in premenopausal women veterans.
Specific aims of the study are to;
-
Determine the feasibility, safety, and tolerability of 12-week moderate intensity exercise
-
Explore potential therapeutic benefits of 12-week moderate intensity exercise. Outcome data will include posttraumatic and depressive symptoms.
-
Explore potential therapeutic effects of a 12-week moderate intensity exercise on comorbid pain syndrome and quality of life.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Aerobic Exercise The aerobic exercise intervention is a 12-week program consisting of four 30- to 40-minute exercise sessions of brisk walking per week. |
Behavioral: Aerobic Exercise
12 weeks of brisk walking
|
Outcome Measures
Primary Outcome Measures
- Clinician Administered Posttraumatic Stress Disorder Scale (CAPS) [Changes from baseline to week 12.]
Secondary Outcome Measures
- PTSD Checklist [Changes from baseline to week 12.]
- Inventory of Depressive Symptomatology (Self-Report) (IDS-SR) [Changes from baseline to week 12.]
- Pain Scale [Changes from baseline to week 12.]
- Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) [Changes from baseline to week 12.]
- Safety (Monitoring for common side effects associated with aerobic exercise and adverse events). [12 Weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Women veterans ages 18 and older
-
Premenopausal women of childbearing potential with a negative pregnancy test
-
DSM IV-TR confirmed PTSD related to any traumatic event as measured by Clinician Administered PTSD Scale (CAPS) with a CAPS score of at least 45
-
Relatively low sedentary life style
-
Existing psychotropic medications are allowed if on a stable dose
-
Evidence-based psychotherapy (e.g. Cognitive Processing Therapy or Prolonged Exposure) is not allowed to start of the study. However supportive or educational groups that are not PTSD-focused are allowed.
Exclusion Criteria:
-
Other psychiatric diagnoses including bipolar disorder, schizophrenia, schizoaffective disorder, active substance dependence/abuse (use in the past 1 month), obsessive-compulsive disorder, and eating disorders.Comorbid major depressive disorder, dysthymia and generalized anxiety disorders are not excluded.
-
Serious psychopathology
-
Actively suicidal or homicidal
-
Psychiatric hospitalization within the past 30 days
-
Active medical conditions that preclude the use of aerobic exercise such as uncontrolled hypertension, active musculoskeletal degenerative conditions, and symptomatic cardiovascular or respiratory conditions.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Dallas VA Medical Center | Dallas | Texas | United States | 75216 |
Sponsors and Collaborators
- North Texas Veterans Healthcare System
Investigators
- Principal Investigator: Geetha Shivakumar, M.D., M.S., Dallas VA Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 10N17